Wilmot Cancer Center Honors Expert for Lymphoma Research Success
November 16, 2006
An international leader in lymphoma research and care was honored today by the James P. Wilmot Cancer Center at the University of Rochester Medical Center. Richard I. Fisher, M.D., received the Davey Memorial Award for outstanding contributions to cancer research.
Fisher was recognized for his tremendous contributions to improvements in how doctors treat indolent non-Hodgkin's lymphoma. He published a study that shows advances in therapies and the development of targeted therapies have improved survival by 70 percent for what was once considered an incurable disease. Standard therapies combined with new monoclonal antibodies – which go right after lymphoma cells – are saving lives, which is the goal of every physician and medical researcher
“It’s a great accomplishment when you can see your research save lives. We are proud to honor Dr. Fisher for his contributions to lymphoma treatments throughout his career,” said Hartmut “Hucky” Land, Ph.D., chair of Biomedical Genetics at the Medical Center.
The Davey Memorial Award was established in 1997 in memory of R. Bruce Davey, a local businessman and community leader who lost his battle with cancer in 1996. It is the cancer center’s highest scientific honor presented at the annual scientific symposium.
Fisher has led numerous national and international studies in Hodgkin’s disease and non-Hodgkin’s lymphoma and has published hundreds of articles. Patients and physicians throughout the U.S. seek his expertise on lymphoma treatment.
He joined the Medical Center in 2001 as director of the Wilmot Cancer Center and is credited with re-energizing the scientific and clinical programs. He has outlined an aggressive strategy to create one of the top cancer centers in the country in Rochester. Robust research programs are key to securing the National Cancer Institute’s designation and we are proud to support the Wilmot strategic plan for the future.
A graduate of Harvard College and Harvard Medical School, Dr. Fisher completed an internship and residency at Massachusetts General Hospital. He held an oncology fellowship and worked as a senior investigator at the NCI from 1972 to 1984.